Published in Acta Endocrinol (Copenh) on June 01, 1983
Drugs that target dynamic microtubules: a new molecular perspective. Med Res Rev (2011) 1.70
2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci U S A (1994) 1.43
The biology of preeclampsia. Kidney Int (2009) 1.16
Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions. Am J Pathol (2010) 1.03
Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges. Mol Pharm (2010) 1.00
2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation. Proc Natl Acad Sci U S A (2012) 0.87
Opposite regulation of XIAP and Smac/DIABLO in the rat endometrium in response to 17beta-estradiol at estrus. Reprod Biol Endocrinol (2003) 0.86
Synergistic apoptosis of MCF-7 breast cancer cells by 2-methoxyestradiol and bis(ethyl)norspermine. Cancer Lett (2006) 0.81
The role of genetics in pre-eclampsia and potential pharmacogenomic interventions. Pharmgenomics Pers Med (2012) 0.81
Mouse models for preeclampsia: disruption of redox-regulated signaling. Reprod Biol Endocrinol (2009) 0.81
Metabolic pathways involved in 2-methoxyestradiol synthesis and their role in preeclampsia. Reprod Sci (2013) 0.81
2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism. Am J Physiol Endocrinol Metab (2016) 0.77
DNA strand breaks induced by nuclear hijacking of neuronal NOS as an anti-cancer effect of 2-methoxyestradiol. Oncotarget (2015) 0.76
O-methylation of catechol estrogens by human placental catechol-o-methyltransferase: interindividual differences in sensitivity to heat inactivation and to inhibition by dietary polyphenols. Drug Metab Dispos (2010) 0.76
Estradiol 17β and its metabolites stimulate cell proliferation and antagonize ascorbic acid-suppressed cell proliferation in human ovarian cancer cells. Reprod Sci (2013) 0.76
Urinary excretion of catecholestrogens, 2-methoxy-estrogens and "classical estrogens" throughout the normal menstrual cycle. Arch Gynecol Obstet (1991) 0.76
Protective Role of Maternal P.VAL158MET Catechol-O-Methyltransferase Polymorphism against Early-Onset Preeclampsia and its Complications. J Med Biochem (2016) 0.75
2-Methoxyestradiol Alleviates Experimental Autoimmune Uveitis by Inhibiting Lymphocytes Proliferation and T Cell Differentiation. Biomed Res Int (2016) 0.75
Sildenafil Therapy Normalizes the Aberrant Metabolomic Profile in the Comt(-/-) Mouse Model of Preeclampsia/Fetal Growth Restriction. Sci Rep (2015) 0.75
The relevance of the Renin-Angiotensin system in the development of drugs to combat preeclampsia. Int J Endocrinol (2015) 0.75
2-methoxyestradiol plasma levels are associated with clinical severity indices and biomarkers of preeclampsia. Reprod Sci (2014) 0.75
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet (2001) 2.06
Physical studies on ribonucleic acid polymerase from Escherichia coli B. Biochemistry (1970) 1.80
Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann Neurol (1999) 1.74
Localized Darier disease. Implications for genetic studies. Arch Dermatol (1997) 1.65
GBA-associated PD presents with nonmotor characteristics. Neurology (2011) 1.63
Early natural course of transient encephalopathy after coronary artery bypass grafting. Crit Care Med (2000) 1.52
EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol (2013) 1.52
Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ (2010) 1.52
Differentiation between intracerebral hemorrhage and ischemic stroke by transcranial color-coded duplex-sonography. Stroke (1998) 1.45
Boost irradiation of breast carcinoma: teletherapy vs. brachytherapy. Eur J Obstet Gynecol Reprod Biol (2001) 1.40
[Inhuman practices at the 1st Gynecologic Clinic of the Munich University]. Geburtshilfe Frauenheilkd (1995) 1.39
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology (2008) 1.39
Direct primary closure without undermining in the repair of vermilionectomy defects of the lower lip. Br J Dermatol (2012) 1.38
Interleukin-10 gene knock-out mice: a model of chronic inflammation. Clin Immunol Immunopathol (1995) 1.34
Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: genetic and epidemiologic analyses. J Clin Microbiol (2000) 1.27
Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry (2005) 1.16
Screening for mutations in synaptotagmin XI in Parkinson's disease. J Neural Transm Suppl (2004) 1.07
Cerebral activation patterns in patients with writer's cramp: a functional magnetic resonance imaging study. J Neurol (2001) 1.05
Circadian rhythm of serum unconjugated estriol in late pregnancy. J Clin Endocrinol Metab (1974) 1.04
Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology (2004) 1.03
Prodromal features for Parkinson's disease--baseline data from the TREND study. Eur J Neurol (2014) 1.03
Periparotid lupus erythematosus panniculitis. Clinicopathologic correlation of two cases presenting as primary parotid disease. Arch Pathol Lab Med (1993) 1.02
In vivo restoration of RhoB expression leads to ovarian tumor regression. Cancer Gene Ther (2008) 1.02
Acute effects of nitrogen dioxide after accidental release. Public Health Rep (1998) 1.02
Genotypic analysis of Staphylococcus aureus from milk of dairy cows with mastitis in Argentina. Epidemiol Infect (2001) 1.02
Duty to recall. South Med J (1980) 1.01
Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Neuroreport (2000) 0.98
Novel ATP1A3 mutation in a sporadic RDP patient with minimal benefit from deep brain stimulation. Neurology (2008) 0.97
Interleukin 10: an overview. Prog Growth Factor Res (1992) 0.97
Improvement of balance after audio-biofeedback. A 6-week intervention study in patients with progressive supranuclear palsy. Z Gerontol Geriatr (2010) 0.96
Genetic analysis of immunomodulating factors in sporadic Parkinson's disease. J Neural Transm (Vienna) (2000) 0.95
Tumoral calcinosis. Br J Surg (1972) 0.92
Bifonazole and clotrimazole. Their mode of action and the possible reason for the fungicidal behaviour of bifonazole. Arzneimittelforschung (1984) 0.92
Cross-sectional study discloses a positive family history for Parkinson's disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity. J Neural Transm (Vienna) (2007) 0.91
Basal limbic system alteration in major depression: a hypothesis supported by transcranial sonography and MRI findings. Int J Neuropsychopharmacol (2001) 0.90
Baroreflex sensitivity and power spectral analysis in different extrapyramidal syndromes. J Neural Transm (Vienna) (2008) 0.90
Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound. Mov Disord (2001) 0.89
Psychopathological symptoms of depression in Parkinson's disease compared to major depression. Psychopathology (2003) 0.89
Norepinephrine, active norepinephrine transporter, and norepinephrine-metabolism are involved in the generation of reactive oxygen species in human ovarian granulosa cells. Endocrinology (2012) 0.88
Serum concentration and urinary excretion of "classical" estrogens, catecholestrogens and 2-methoxyestrogens in normal human pregnancy. Arch Gynecol Obstet (1992) 0.88
The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populations. J Med Genet (2006) 0.88
Measurements of Cs absorption and retention in man. Health Phys (1989) 0.88
Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease. Neurology (2004) 0.87
Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia. J Mol Med (Berl) (1998) 0.87
Management of severe hypokalemia in hospitalized patients: a study of quality of care based on computerized databases. Arch Intern Med (2001) 0.87
Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol (2006) 0.86
Deciphering signaling pathways in clinical tissues for personalized medicine using protein microarrays. J Cell Physiol (2010) 0.86
Targeted therapies in cancer - challenges and chances offered by newly developed techniques for protein analysis in clinical tissues. J Cancer (2010) 0.86
Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools. Acta Neurol Scand (2013) 0.86
[Water-soluble metabolites of estradiol-17beta. II]. Hoppe Seylers Z Physiol Chem (1968) 0.85
Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by F-Dopa PET. Neuroimage (2009) 0.85
Oligonucleotides containing 2-aminoadenine and 5-methylcytosine are more effective as primers for PCR amplification than their nonmodified counterparts. Genet Anal (1996) 0.85
Use of THAM and sodium bicarbonate in correcting acidosis in asphyxiated newborns. Arch Dis Child (1969) 0.84
UPA and PAI-1 analysis from fixed tissues - new perspectives for a known set of predictive markers. Curr Med Chem (2010) 0.84
[A water-soluble metabolite of 17-beta-estradiol]. Hoppe Seylers Z Physiol Chem (1967) 0.84
[Estrogens in pregnancy. I. A rapid and reliable radioimmunologic method for estriol determination in the serum of pregnant women]. Geburtshilfe Frauenheilkd (1974) 0.84
[Microblood study on the fetus. II. Physiology of fetal acidosis]. Arch Gynakol (1966) 0.83
Quality of life in patients with blepharospasm. Acta Neurol Scand (2001) 0.83
Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells. Gene Ther (2006) 0.83
Valsalva manoeuvre in patients with different Parkinsonian disorders. J Neural Transm (Vienna) (2009) 0.83
Oxytocin receptors in the primate ovary: molecular identity and link to apoptosis in human granulosa cells. Hum Reprod (2010) 0.82
Increased tissue copper and manganese content in the lentiform nucleus in primary adult-onset dystonia. Ann Neurol (1999) 0.82
Differences in substantia nigra echogenicity of nosological subtypes within the schizophrenic spectrum. A preliminary transcranial ultrasound study. Neuropsychobiology (2001) 0.82
No association of GBA mutations and multiple system atrophy. Eur J Neurol (2013) 0.82
Determination of estrogens by radioimmunoassay with antibodies to estrogen-C6-conjugates. I. Synthesis of estrone-, estradiol-17 -, and estriol-6-albumin conjugates. Steroids (1972) 0.82
Environmental behaviour of radionuclides deposited after the reactor accident of Chernobyl and related exposures. Radiat Environ Biophys (1993) 0.82
Inherited Myoclonus-dystonia syndrome: narrowing the 7q21-q31 locus in German families. Ann Neurol (2001) 0.82
The role of alpha-synuclein gene multiplications in early-onset Parkinson's disease and dementia with Lewy bodies. J Neural Transm (Vienna) (2004) 0.82
Human placental sterylsulfatase: immunocytochemical and biochemical localization. Biol Chem Hoppe Seyler (1989) 0.81
[Venous diseases and the population structure]. Vasa Suppl (1991) 0.81
Concentrations of 2-hydroxyoestrogens in human sera measured by a heterologous immunoassay with an 125I-labelled ligand. Acta Endocrinol (Copenh) (1982) 0.81
Association of histologic chorioamnionitis, increased levels of cord blood cytokines, and intracerebral hemorrhage in preterm neonates. Biol Neonate (2003) 0.81
Lipoprotein lipase compensates for the defective function of apo E variants in vitro by interacting with proteoglycans and lipoprotein receptors. Atherosclerosis (1999) 0.81
Steroids as immunochemical probes, I. Influence of oxo-, and-or hydroxy-groups at C-16-C-17 of estrogens on affinity to anti-estrone-, anti-estradiol-17 alpha- and anti-estradiol-17beta-antisera. Hoppe Seylers Z Physiol Chem (1973) 0.81
Relation of risk factors and putative premotor markers for Parkinson's disease. J Neural Transm (Vienna) (2011) 0.81
Linkage analysis between schizophrenia and the Darier's disease region on 12q. Psychiatr Genet (1996) 0.81
Genetic analysis of a severe case of Netherton syndrome and application for prenatal testing. Br J Dermatol (2002) 0.81
Comparative study of the incorporation of ellipticine-esters into low density lipoprotein (LDL) and selective cell uptake of drug--LDL complex via the LDL receptor pathway in vitro. Biochem Pharmacol (1990) 0.81
Transcranial sonography in spinocerebellar ataxia type 3. J Neural Transm Suppl (2004) 0.81
Does ultrasound disclose a vulnerability factor for Parkinson's disease? J Neurol (2003) 0.81
[Microsomal oxidation of estradiol-17 beta. 2-hydroxylation and 1- respectively 4- thioether production with and without 17-hydroxy dehydrogenation]. Hoppe Seylers Z Physiol Chem (1971) 0.81
The cold hand sign in multiple system atrophy: skin perfusion revisited. J Neural Transm (Vienna) (2010) 0.80
Comprehensive association analysis of the NOS2A gene with Parkinson disease. Neurology (2006) 0.80
Specific antibodies for radioimmunoassay of 4-hydroxyestrogens and their characterization by 125I-labelled indicator haptens. Hoppe Seylers Z Physiol Chem (1980) 0.80
[Contribution on buffer selection in the treatment of acidosis in newborn infants, with special reference to the buffer effect on respiration]. Arch Gynakol (1968) 0.80
[Water-soluble metabolites of estradiol-17-beta. 3. Separation and identification of 1- and 4-glutathione thioethers of 2,3-dihydroxy-estratrienes]. Hoppe Seylers Z Physiol Chem (1969) 0.80
Changes in patient perception and behavior following Mohs micrographic surgery. J Cutan Med Surg (2001) 0.80
Radioimmunologic determination of plasma estriol in pregnancy with anti-estriol-C6 conjugate-antiserum. Acta Endocrinol Suppl (Copenh) (1973) 0.80
Substantia nigra echomorphology and motor cortex excitability. Neuroimage (2010) 0.80
Specific radioimmunological determination without chromatography of plasma oestradiol in males. Acta Endocrinol (Copenh) (1973) 0.79
Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi. Chemotherapy (2008) 0.79
The influence of Nordic Walking training on sit-to-stand transfer in Parkinson patients. Gait Posture (2011) 0.79
Dopamine in human follicular fluid is associated with cellular uptake and metabolism-dependent generation of reactive oxygen species in granulosa cells: implications for physiology and pathology. Hum Reprod (2013) 0.79
Reduction of the in vivo virulence of Candida albicans by pretreatment with subinhibitory azole concentrations in vitro. Dermatologica (1984) 0.79
Test methods for antifungal agents--a critical review. Mykosen (1987) 0.79
[Non-conjugated estrogens in the peripartal period in normal and pathologic pregnancies]. Arch Gynakol (1975) 0.79